Hotel Gołębiewski - Mikołajki,Wisła,Karpacz, Białystok-TAGO.

[lily9889]

Remdesivir: Five India and Pakistan firms to make drug to
'fight coronavirus'



A US pharmaceutical firm has signed agreements with drug makers in South Asia to expand supply of
the drug remdesivir for treating Covid-19.

The agreement between Gilead and five generic pharmaceutical companies in India and Pakistan will
help make the medicine for 127 countries.

Remdesivir cut the duration of symptoms from 15 days to 11 in clinical trials at hospitals around the world.

The antiviral drug was originally developed as an Ebola treatment.

It works by attacking an enzyme that a virus needs in order to replicate inside our cells.

Under the licensing agreement, the five companies have the "right to receive a technology transfer
of the Gilead manufacturing process for remdesivir to enable them to scale up their production quickly",
a statement from Gilead said.

The licenses would be royalty-free until the World Health Organisation (WHO) declares the end
of the public health emergency arising out of Covid-19, or until another pharmaceutical product
or a vaccine is approved to treat or prevent the disease, the statement said.

The agreements allow the Cipla Limited, Ferozsons Laboratories, Hetero Labs Ltd, Jubilant Lifesciences
and Mylan to manufacture the drug.


Follow the real-life Covid-19 news here. : slotxo

[Reklama]